Pharma M&A AstraZeneca and Pfizer bid of interest

Pharma M&A Games Afoot: Pfizer is interested in AstraZeneca

AstraZeneca’s shares increased 15% on Monday morning, after US drugs giant Pfizer announced its interest in acquiring the UK company. This is the second time the company has approached AstraZeneca within a short time frame. City analyst, Andrew Baum, believed that there was now a 90% chance that Pfizer would achieve its objectives.   Pfizer approached AstraZeneca in January, with …